1. 3054 Health-related quality of life in elderly patients with advanced non-small-cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy in the Phase 3 IFCT-0501 trial. (September 2015) Authors: Fiteni, F.; Anota, A.; Bonnetain, F.; Milleron, B.; Zalcman, G.; Quoix, E.; Westeel, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3100 Phase Ib/II study of the pan-cyclin-dependent kinase (CDK) inhibitor roniciclib (BAY 1000394) in combination with chemotherapy as first-line therapy in subjects with extensive disease small cell lung cancer (ED-SCLC). (September 2015) Authors: Cho, B.C.; Dy, G.K.; Govindan, R.; Kim, D.W.; Pennell, N.A.; Zalcman, G.; Besse, B.; Nogai, H.; Rajagopalan, P.; Ocker, M.; Barlesi, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3128 EGFR, ALK, KRAS prognostic value in a large French prospective cohort of non-previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort. (September 2015) Authors: Cadranel, J.; Quoix, E.; Duruisseaux, M.; Friard, S.; Fabre, E.; Daniel, C.; Westeel, V.; Madroszyk, A.; Lena, H.; Merle, P.; Mazieres, J.; Dansin, E.; Scherpereel, A.; Hiret, S.; Coudert, B.; Souquet, P.J.; Missy, P.; Morin, F.; Zalcman, G.; Barlesi, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 4P FDG PET derived metabolic tumor volume (MTV) and its transcriptomic correlates as biomarker to predict efficacy of immune checkpoint inhibitors (ICB) alone or in combination with chemotherapy in advanced NSCLC: A multicentric study. (December 2022) Authors: Dall'Olio, F.G.; Garcia, C.A.; Zrafi, W.S.; Fortunati, E.; Bettayeb, A.; Zalcman, G.; Remon Masip, J.; Hendriks, L.; Tagliamento, M.; Bonardel, G.; Helissey, C.; Roelants, V.; Fourquet, A.; Aboubakar, F.; Chaput-Gras, N.; Passiglia, F.; Monnet, I.; Planchard, D.; Barlesi, F.; Besse, B. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 98O_PRTARGETED THERAPY FOR BRAF-MUTANT LUNG CANCER: RESULTS FROM THE EUROPEAN EURAF COHORT STUDY. (17th April 2015) Authors: Gautschi, O.; Bluthgen, M.V.; Smit, E.F.; Wolf, J.; Früh, M.; Peters, S.; Schuler, M.; Zalcman, G.; Milia, J.; Mazieres, J. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 1 Page Start: i61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. (February 2021) Authors: Abbar, B.; De Castelbajac, V.; Gougis, P.; Assoun, S.; Pluvy, J.; Tesmoingt, C.; Théou-Anton, N.; Cazes, A.; Namour, C.; Khalil, A.; Gounant, V.; Besse, B.; Zalcman, G.; Brosseau, S. Journal: Lung cancer Issue: Volume 152(2021) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nivolumab-induced organizing pneumonitis in a patient with lung sarcomatoid carcinoma. (September 2016) Authors: Gounant, V.; Brosseau, S.; Naltet, C.; Opsomer, M.-A.; Antoine, M.; Danel, C.; Khalil, A.; Cadranel, J.; Zalcman, G. Journal: Lung cancer Issue: Volume 99(2016) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗